GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Axsome Therapeutics Inc (LTS:0HKF) » Definitions » Shiller PE Ratio

Axsome Therapeutics (LTS:0HKF) Shiller PE Ratio : (As of Sep. 25, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Axsome Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Axsome Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Axsome Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Axsome Therapeutics Shiller PE Ratio Chart

Axsome Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Axsome Therapeutics Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Axsome Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Axsome Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Axsome Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Axsome Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Axsome Therapeutics's Shiller PE Ratio falls into.



Axsome Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Axsome Therapeutics's E10 for the quarter that ended in Jun. 2024 is calculated as:

For example, Axsome Therapeutics's adjusted earnings per share data for the three months ended in Jun. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=-1.67/132.5538*132.5538
=-1.670

Current CPI (Jun. 2024) = 132.5538.

Axsome Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201409 -0.020 100.428 -0.026
201412 -0.117 99.070 -0.157
201503 -0.168 99.621 -0.224
201506 -0.167 100.684 -0.220
201509 -0.258 100.392 -0.341
201512 -0.120 99.792 -0.159
201603 -0.310 100.470 -0.409
201606 -0.360 101.688 -0.469
201609 -0.380 101.861 -0.495
201612 -0.380 101.863 -0.494
201703 -0.410 102.862 -0.528
201706 -0.300 103.349 -0.385
201709 -0.270 104.136 -0.344
201712 -0.310 104.011 -0.395
201803 -0.190 105.290 -0.239
201806 -0.320 106.317 -0.399
201809 -0.310 106.507 -0.386
201812 -0.320 105.998 -0.400
201903 -0.320 107.251 -0.395
201906 -0.410 108.070 -0.503
201909 -0.560 108.329 -0.685
201912 -0.710 108.420 -0.868
202003 -0.880 108.902 -1.071
202006 -0.490 108.767 -0.597
202009 -0.610 109.815 -0.736
202012 -0.780 109.897 -0.941
202103 -0.780 111.754 -0.925
202106 -0.860 114.631 -0.994
202109 -0.930 115.734 -1.065
202112 -0.900 117.630 -1.014
202203 -1.030 121.301 -1.126
202206 -1.060 125.017 -1.124
202209 -1.070 125.227 -1.133
202212 -1.410 125.222 -1.493
202303 -0.260 127.348 -0.271
202306 -1.540 128.729 -1.586
202309 -1.320 129.860 -1.347
202312 -2.080 129.419 -2.130
202403 -1.440 131.776 -1.448
202406 -1.670 132.554 -1.670

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Axsome Therapeutics  (LTS:0HKF) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Axsome Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Axsome Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Axsome Therapeutics Business Description

Traded in Other Exchanges
Address
22 Cortlandt Street, 16th Floor, New York, NY, USA, 10007
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14.

Axsome Therapeutics Headlines

No Headlines